EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,265,000 | -10.0% | 882,072 | +4.3% | 0.04% | -15.1% |
| Q3 2017 | $9,187,000 | -0.6% | 845,985 | -6.1% | 0.05% | -5.4% |
| Q2 2017 | $9,247,000 | +12.8% | 901,359 | +0.2% | 0.06% | +7.7% |
| Q1 2017 | $8,198,000 | -24.0% | 899,968 | +4.4% | 0.05% | -26.8% |
| Q4 2016 | $10,780,000 | +23.4% | 862,432 | +2.7% | 0.07% | +20.3% |
| Q3 2016 | $8,739,000 | +5.9% | 839,511 | +2.8% | 0.06% | +3.5% |
| Q2 2016 | $8,252,000 | +3.6% | 816,295 | -6.3% | 0.06% | +3.6% |
| Q1 2016 | $7,968,000 | -26.8% | 870,908 | -0.8% | 0.06% | -24.7% |
| Q4 2015 | $10,886,000 | – | 877,984 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |